4
Changes in Ownership
DiaMedica Therapeutics Inc. Filed Acc 0001235802-19-000066
Options or other derivatives
- Chief Scientific Officer acquired 71,025 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Verdoorn Todd A. Chief Scientific Officer | 2019-06-24 | Grant or award · Stock Option (right to buy) | +71,025 | 71,025 | D | ||
Loading xslF345X03/primary_doc.xml…